---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-001114"
form_type: "8-K"
ticker: "SBEV"
cik: "0001553788"
company_name: "SPLASH BEVERAGE GROUP, INC."
filed_at: "2026-08-20T13:06:08+00:00"
generated_at: "2026-08-20T13:07:07.021072+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Splash Beverage Q2 loss narrows 64% to ~$4M; rebranding as Endovia Health Sciences

## Summary
- H1 2026 loss from continuing ops ~$4M vs ~$11M in H1 2025, improvement of ~$7M (64%).
- In early July 2026, entered exclusive global license for CannEpil®, a pharma-grade cannabinoid platform for drug-resistant epilepsy.
- On Jul 31 2026, signed development agreement with Lupvindol Biosciences to advance CannEpil® veterinary product through FDA INAD and Conditional Approval.
- Rebrand to Endovia Health Sciences with name and ticker change effective on NYSE American Aug 24, 2026.
- Preparing to relaunch CannEpil® in UK, Ireland and select Latin American markets through existing distribution.

## SEC filing metadata
- accession: 0001731122-26-001114
- form_type: 8-K
- ticker: SBEV
- cik: 0001553788
- company_name: SPLASH BEVERAGE GROUP, INC.
- filed_at: 2026-08-20T13:06:08+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553788/000173112226001114/0001731122-26-001114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553788/000173112226001114/e7875_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-001114
- JSON: https://secwatch.observer/filing/0001731122-26-001114.json
- Plain text: https://secwatch.observer/filing/0001731122-26-001114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.